Next, we compared the expression levels of genes involved in ECM degradation, such as matrix metalloproteinase (MMP)1, MMP9, and MMP14, which were previously reported to be elevated in LVI-positive breast cancers [31,32,33]. The gene discussed is MMP1; the disease is breast cancer.